DCGI

Latest news and video coverage curated from trusted media outlets


0 shares	Share Tweet Save Post Send



‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the.. Credit: HT Digital Content Duration: 01:40Published on January 13, 2021

Explained: India announces Covid vaccination launch date; who's first in line? The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had.. Credit: HT Digital Content Duration: 01:34Published on January 9, 2021

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine.. Credit: HT Digital Content Duration: 04:32Published on January 5, 2021

Covid-19: First vaccine shots likely on January 13th, countdown begins\|Oneindia News Indians can expect to get their first COVID-19 vaccine shot on January 13. Union Health Ministry announced on Tuesday that the Centre is all set to roll out coronavirus vaccines within 10 days of.. Credit: Oneindia Duration: 01:00Published on January 5, 2021

'Who will opt for vaccine...': Congress questions approval, slams govt Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid.. Credit: HT Digital Content Duration: 03:25Published on January 5, 2021

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company. On.. Credit: HT Digital Content Duration: 08:59Published on January 4, 2021

82-year-old Briton gets first dose of Oxford vaccine Britain has begun vaccinating its citizens with the AstraZeneca/Oxford vaccine against COVID-19 on January 04. The first shot was given to Brian Pinker, an 82-year-old dialysis patient, at a hospital.. Credit: ANI Duration: 01:10Published on January 4, 2021

Won't get vaccinated for now, priority groups should be served first: Shivraj Chouhan Madhya Pradesh Chief Minister Shivraj Singh Chouhan on January 04 said that he will not get vaccinated against COVID-19 for now, as he wants the priority groups to be served first. "I have decided that.. Credit: ANI Duration: 01:10Published on January 4, 2021

‘Don’t know how long the Covid vaccines will be effective for’: DG-ICMR Dr Balram Bhargava, Director General of Indian Council of Medical Research (ICMR) hailed the Covid-19 vaccines hours after Drugs Controller General of India (DCGI) gave its nod to Serum Institute of.. Credit: HT Digital Content Duration: 02:35Published on January 4, 2021

Healthcare, frontline workers will be vaccinated in 1st phase: Delhi Health Minister Health Minister of Delhi, Satyendar Jain informed about plans to begin vaccination after DCGI granted approval to vaccines of Serum Institute of India and Bharat Biotech. Jain said, "In the first.. Credit: ANI Duration: 02:03Published on January 3, 2021

स्वदेशी कोवैक्सीन सहित कोविशील्ड को मिली DGCI की म� कोरोना को लेकर जंग लड़ रहे भारत को आज वैक्सीन के रूप में दो नए हथियार मिल गए.. Credit: HT Digital Content Duration: 04:03Published on January 3, 2021

DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech Drugs Controller General of India VG Somani on January 03 informed that COVID-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in emergency.. Credit: ANI Duration: 02:10Published on January 3, 2021

30 crore people to be vaccinated in 1st phase: Cardiologist As country is eagerly waiting for COVID-19 vaccination programme to begin, Dr. Manoj Kumar, Senior Cardiologist at Max Hospital, Delhi informed that in the first phase, almost 30 crore population will.. Credit: ANI Duration: 01:13Published on January 2, 2021

Covid-19: SII seeks emergency use nod for Oxford vaccine Covishield in India The Serum Institute of India (SSI) has sought emergency use authorisation from the Drugs Controller General of India (DCGI) for Oxford Covid-19 vaccine in the country. SII applied to DCGI, citing unmet.. Credit: HT Digital Content Duration: 01:59Published on December 7, 2020

You Might Like

Russia`s COVID-19 vaccine Sputnik V arrives in Hyderabad Last month, the Drug Controller General (DCGI) had issued permission for Dr. Reddy's Laboratories to import the Russian vaccine to India for emergency use. The rollout of the Russian vaccine is.. Zee News - Published 6 days ago
Hyderabad firm gets nod for Covid antidote VINCOV-19 trials Immunologicals player VINS Bioproducts Ltd on Monday said it has received approval from the Drugs Controller General of India (DCGI) for conducting clinical trials of its Covid-19 antidote VINCOV-19. IndiaTimes - Published 2 weeks ago
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19 newKerala.com - Published 2 weeks ago

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin IndiaTimes - Published 2 weeks ago
Bombay High Court calls for more Remdesivir for Maharashtra The Nagpur bench of the Bombay High Court on Friday requested the Drugs Controller General of India (DCGI) for more vials of Remdesivir for Maharashtr Hindu - Published 2 weeks ago
Zydus Cadila gets DCGI nod for hepatitis drug ‘Virafin’ for COVID-19 treatment Indian Express - Published 2 weeks agoAlso reported by •IndiaTimes •Hindu

Zydus Cadila's 'Virafin' gets DCGI nod for emergency use to treat COVID-19 patients The company has said that 91.15 per cent of patients treated with the drug were RT-PCR negative by day seven. DNA - Published 2 weeks ago
Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines The Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines specifying regulatory pathway for approval.. IndiaTimes - Published 3 weeks ago
DCGI nod paves way for Sputnik V vaccine import: Dr. Reddy’s Sputnik V will join Covishield and Covaxin that were approved and used since India launched what arguably is one of the largest inoculation programmes globally in January Hindu - Published on April 13, 2021
Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations... IndiaTimes - Published on April 13, 2021

Will produce over 850 mn doses in India annually: RDIF after DCGI clears Sputnik V COVID-19 vaccine The Russian Direct Investment Fund said that India has become the 60th country to approve the Sputnik V coronavirus vaccine. Zee News - Published on April 13, 2021
Russia hopes approval to Sputnik-V vaccine by DCGI will be completed soon Russia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it was recommended for use in India by a.. IndiaTimes - Published on April 12, 2021
Russian`s Sputnik V COVID-19 vaccine gets approval for emergency use in India The Drugs Controller General of India (DCGI) will take a final call on the recommendation. Once approved, the vaccine would be imported from Russia for emergency use in the country. Zee News - Published on April 12, 2021	Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose.. IndiaTimes - Published on April 2, 2021
Alkem Makes Epilepsy Treatment More Accessible & Affordable with the Launch of BRIVASURE (Brivaracetam) · Epilepsy is a common neurological disorder. Of the 70 million persons with epilepsy (PWE) worldwide, nearly 12 million PWE are expected to reside in India; which contributes to nearly one-sixth of.. NewsVoir - Published on March 16, 2021	IMA demands explanation from Centre over Patanjali`s claim on COVID-19 medicine Coronil Patanjali's managing director Acharya Balkrishna had said, "We want to clarify to avoid confusion that our WHO GMP compliant COPP certificate to Coronil is issued by DCGI, Government of India. It is.. Zee News - Published on February 22, 2021
Coronavirus live updates \| Health Minister asks healthcare, frontline workers to get vaccinated Union Health Minister Harsh Vardhan assures the medical community that both the vaccines cleared by the Drugs Controller General of India (DCGI) are safe and immunogenic. Hindu - Published on February 20, 2021	Dr Reddy's initiates process for emergency use authorisation of Sputnik V Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine.. IndiaTimes - Published on February 19, 2021
Delhi HC pulls up DCGI, expresses shock on missing report Indian Express - Published on February 17, 2021	Chennai Based Doctor Proctors the First Laser Atherectomy in India Dr. Arun Kalyanasundaram, one of India's renowned cardiologists, has successfully proctored Indias first laser atherectomy to treat a complex heart blockage in a middle aged woman at Raipur. *Promed.. NewsVoir - Published on February 4, 2021
Serum Institute seeks DCGI nod for clinical trials of Covid-19 vaccine Covavax IndiaTimes - Published on January 30, 2021	Sputnik V vaccine launch likely in March Dr. Reddy’s Laboratories is expecting Emergency Use Authorisation from the Drugs Controller General of India (DCGI) for Russia’s COVID-19 vaccine Sput Hindu - Published on January 29, 2021
Plea in Bombay HC seeks info on safety, efficacy of ‘Covaxin’ from DCGI Indian Express - Published on January 16, 2021	DCGI nod for phase 3 trials for Sputnik V vaccine Dr Reddy’s to conduct trial on 1,500 subjects Hindu - Published on January 15, 2021

DCGI

Latest news and video coverage curated from trusted media outlets

You Might Like

Russia`s COVID-19 vaccine Sputnik V arrives in Hyderabad

Hyderabad firm gets nod for Covid antidote VINCOV-19 trials

VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

Bombay High Court calls for more Remdesivir for Maharashtra

Zydus Cadila gets DCGI nod for hepatitis drug ‘Virafin’ for COVID-19 treatment

Zydus Cadila's 'Virafin' gets DCGI nod for emergency use to treat COVID-19 patients

Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

DCGI nod paves way for Sputnik V vaccine import: Dr. Reddy’s

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Will produce over 850 mn doses in India annually: RDIF after DCGI clears Sputnik V COVID-19 vaccine

Russia hopes approval to Sputnik-V vaccine by DCGI will be completed soon

Russian`s Sputnik V COVID-19 vaccine gets approval for emergency use in India

Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin

Alkem Makes Epilepsy Treatment More Accessible & Affordable with the Launch of BRIVASURE (Brivaracetam)

IMA demands explanation from Centre over Patanjali`s claim on COVID-19 medicine Coronil

Coronavirus live updates | Health Minister asks healthcare, frontline workers to get vaccinated

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Delhi HC pulls up DCGI, expresses shock on missing report

Chennai Based Doctor Proctors the First Laser Atherectomy in India

Serum Institute seeks DCGI nod for clinical trials of Covid-19 vaccine Covavax

Sputnik V vaccine launch likely in March

Plea in Bombay HC seeks info on safety, efficacy of ‘Covaxin’ from DCGI

DCGI nod for phase 3 trials for Sputnik V vaccine